Shandong Weigao Group Medical Polymer. 

$1.5950
22
+$0.10+7.05% Friday 15:46

Statistics

Day High
1.68
Day Low
1.59
52W High
3.51
52W Low
1.49
Volume
626
Avg. Volume
546
Mkt Cap
0
P/E Ratio
8.95
Dividend Yield
5.62%
Dividend
0.09

Upcoming

Dividends

5.62%Dividend Yield
Dec 25
$0.05
Jul 25
$0.07
Dec 24
$0.05
Jul 24
$0.05
Dec 23
$0.04
10Y Growth
6.84%
5Y Growth
-0.07%
3Y Growth
1.62%
1Y Growth
-26.97%

Earnings

2SepExpected
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Next
0
0.09
0.19
0.28
Expected EPS
0.18437090784000001
Actual EPS
N/A

Financials

15.79%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
3.59BRevenue
567.09MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SHWGY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap101.56B
Medtronic is a global leader in medical technology, services, and solutions, competing directly in the medical devices sector with Shandong Weigao Medical Polymer.
Boston Scientific
BSX
Mkt Cap67.32B
Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, competing in areas such as cardiovascular and endoscopy products.
Stryker
SYK
Mkt Cap118B
Stryker Corporation specializes in reconstructive, medical and surgical, and neurotechnology and spine products, directly competing with Shandong Weigao's range of medical devices.
Zimmer Biomet
ZBH
Mkt Cap17.02B
Zimmer Biomet Holdings, Inc. is a competitor in the musculoskeletal healthcare sector, offering products that compete with Shandong Weigao's orthopedic and surgical devices.
Abbott Laboratories
ABT
Mkt Cap153.99B
Abbott Laboratories operates in various segments, including medical devices, competing with Shandong Weigao in areas like vascular and diabetes care.
Johnson & Johnson
JNJ
Mkt Cap549.78B
Johnson & Johnson operates in the healthcare field, with its medical devices segment offering products that compete across several of Shandong Weigao's product lines.
Baxter International
BAX
Mkt Cap10.27B
Baxter International Inc. provides a broad portfolio of essential healthcare products, including advanced surgical equipment and devices, competing in the medical supplies and devices sector.
Becton Dickinson
BDX
Mkt Cap39.67B
Becton, Dickinson and Company is a global medical technology company that manufactures and sells medical devices, instrument systems, and reagents, competing in the medical supplies field.
Edwards Lifesciences
EW
Mkt Cap50.3B
Edwards Lifesciences Corporation specializes in heart valves and hemodynamic monitoring, competing with Shandong Weigao in the cardiovascular device market.
Intuitive Surgical
ISRG
Mkt Cap144.07B
Intuitive Surgical, Inc. develops, manufactures, and markets robotic products for minimally invasive surgery, competing in the innovative surgical devices and equipment sector.

About

Shandong Weigao Group Medical Polymer Company Limited, established in 2000 and based in Weihai, People's Republic of China, is primarily engaged in the research, development, manufacturing, and distribution of disposable medical products within the PRC and for export. The company operates through several specialized divisions: Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and other related ventures. Its comprehensive product range includes a vast array of single-use clinical items such as vascular and non-vascular access devices (e.g., infusion sets, syringes, various puncture needles), along with specialized collection kits. It also provides solutions for wound care, encompassing sutures, dressings, and cleaning products, as well as support systems for nonvascular catheters used in extracorporeal procedures. In the critical area of blood management, Shandong Weigao supplies equipment for blood collection, storage, separation, and sterilization, in addition to prefilled and flush syringes, and devices for blood collection and glucose testing. Furthermore, its portfolio extends to anesthesia consumables for general, local, and auxiliary applications, intensive care unit (ICU) equipment, and surgical instruments designed for both open and minimally invasive operations. The company also produces orthopedic devices, interventional tools for treating tumors and vascular conditions, various implantation materials, artificial organs, and medical-grade packaging components like PVC granules, plastic bags, and carton boxes. Industrial automation equipment, parts, molds, and hemodialysis apparatus, spanning Type I, Type II, and Type III medical devices, are also part of their extensive offerings. Beyond its core manufacturing activities, the company diversifies into finance leasing and factoring, wholesale distribution of specific medical and surgical disposables, asset management, and offers enterprise consulting and management advisory services, alongside logistics and storage solutions. Its products are marketed under well-known brands such as Jierui, Wego Ortho, Yahua, Bangde, and Hai Xing, serving a broad client base including hospitals, blood banks, other medical facilities, and independent distributors.
Show more...
CEO
Mr. Jing Long
Employees
12719
Country
United States
ISIN
US81941W1018

Listings

0 Comments

Share your thoughts

FAQ

What is Shandong Weigao Group Medical Polymer. stock price today?
The current price of SHWGY is $1.60 USD — it has increased by +7.05% in the past 24 hours. Watch Shandong Weigao Group Medical Polymer. stock price performance more closely on the chart.
What is Shandong Weigao Group Medical Polymer. stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Shandong Weigao Group Medical Polymer. stocks are traded under the ticker SHWGY.
Is Shandong Weigao Group Medical Polymer. stock price growing?
SHWGY stock has fallen by -6.18% compared to the previous week, the month change is a -0.93% fall, over the last year Shandong Weigao Group Medical Polymer. has showed a -50.16% decrease.
When is the next Shandong Weigao Group Medical Polymer. earnings date?
Shandong Weigao Group Medical Polymer. is going to release the next earnings report on September 02, 2026.
What were Shandong Weigao Group Medical Polymer. earnings last quarter?
SHWGY earnings for the last quarter are 0.02 USD per share, whereas the estimation was 0.03 USD resulting in a -27.78% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Shandong Weigao Group Medical Polymer. revenue for the last year?
Shandong Weigao Group Medical Polymer. revenue for the last year amounts to 3.59B USD.
What is Shandong Weigao Group Medical Polymer. net income for the last year?
SHWGY net income for the last year is 567.09M USD.
Does Shandong Weigao Group Medical Polymer. pay dividends?
Yes, SHWGY dividends are paid semi-annual. The last dividend per share was 0.05 USD. As of today, Dividend Yield (FWD)% is 5.62%.
How many employees does Shandong Weigao Group Medical Polymer. have?
As of June 27, 2026, the company has 12,719 employees.
In which sector is Shandong Weigao Group Medical Polymer. located?
Shandong Weigao Group Medical Polymer. operates in the Health & Wellness sector.
When did Shandong Weigao Group Medical Polymer. complete a stock split?
The last stock split for Shandong Weigao Group Medical Polymer. was on May 04, 2011 with a ratio of 2:1.
Where is Shandong Weigao Group Medical Polymer. headquartered?
Shandong Weigao Group Medical Polymer. is headquartered in Weihai, United States.